This activity is expired and is no longer available for CME credit.


Point-Counterpoint: Managing AMD with submacular hemorrhage - monotherapy with anti-VEGF agent

Author(s)/Faculty: Harry W. Flynn Jr., MD; Amir Mohsenin, MD, PhD
Release Date: 12/29/2014Expiration Date: 12/28/2015
Credit Type: CMENumber of Credits: 0
Content Type: MonographProvider:
Drs. Fylnn and Mohsenin review the benefits of anti-vascular endothelial growth factor monotherapy in the treatment of marked submacular hemorrhage due to neovascular age-related macular degeneration.